Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review

Ehsan Raoufi1, Bahar Bahramimeimandi1, M Salehi-Shadkami2

  • 1Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.

Biomedicines
|June 2, 2021
PubMed

Insights

Developing advanced vaccine systems is crucial for combating viral diseases like COVID-19. Nanotechnology offers promising solutions for effective vaccine delivery and protection against degradation.

Area of Science:

  • Immunology and Nanotechnology
  • Vaccine Development and Delivery Systems

Background:

  • The COVID-19 pandemic highlights the need for robust vaccine strategies.
  • Effective vaccines require protection from degradation and targeted delivery.
  • Current approaches face challenges in stability and precision.

Purpose of the Study:

  • To review vaccine design and formulation strategies for various diseases, including SARS-CoV-2.
  • To explore the role of nanotechnology in enhancing vaccine efficacy.
  • To discuss theranostic approaches for targeted compound localization.

Main Methods:

  • Review of scientific literature on vaccine development.
  • Analysis of nanotechnology-based drug and vaccine delivery systems.
  • Examination of theranostic principles in vaccine construction.

Main Results:

  • Nanotechnology-based systems show significant promise for vaccine delivery.
  • Formulation strategies are key to protecting vaccine candidates.
  • Theranostic approaches enable precise targeting and localization of active compounds.

Conclusions:

  • Nanotechnology is a promising platform for developing next-generation vaccines.
  • Advanced formulation and delivery are essential for durable immune responses.
  • Targeted delivery systems are critical for managing viral outbreaks effectively.